Anne Galy, winner of the Biotherapy prize for her project “gene therapy in Wiskott-Aldrich syndrome”
On 22 June, at the 8th annual conference of the “Société Francophone de Thérapie Cellulaire et Génique” (French-speaking Cellular and Gene Therapy Society) in Paris, Anne Galy, Généthon research director of the Inserm unit, will be presented the 2009 Biotherapy prize awarded by Thermo Fisher Scientific Inc. For 12 years, this annual prize has been presented to a French researcher leading an innovative project in the fields of cellular therapy, gene therapy or immunotherapy.
Read the press release – 18/06/09 (1 page – 139 ko)
